Research ArticleClinical Sciences
Comparison of Fluorine-18-2-Fluorodeoxyglucose and Gallium-67 Citrate Imaging for Detection of Lymphoma
Robert Paul
Journal of Nuclear Medicine March 1987, 28 (3) 288-292;
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Comparison of Fluorine-18-2-Fluorodeoxyglucose and Gallium-67 Citrate Imaging for Detection of Lymphoma
Robert Paul
Journal of Nuclear Medicine Mar 1987, 28 (3) 288-292;
Jump to section
Related Articles
- No related articles found.
Cited By...
- How does PET/CT help in selecting therapy for patients with Hodgkin lymphoma?
- PET/CT for Therapy Response Assessment in Lymphoma
- Imaging in staging of malignant lymphoma: a systematic review
- Prognostic value of pretransplantation positron emission tomography using fluorine 18-fluorodeoxyglucose in patients with aggressive lymphoma treated with high-dose chemotherapy and stem cell transplantation
- Thoracic positron emission tomography using 18F-fluorodeoxyglucose for the evaluation of residual mediastinal Hodgkin disease
- Whole-Body Hybrid PET with 18F-FDG in the Staging of Non-Hodgkin's Lymphoma
- Prognostic Value of Positron Emission Tomography (PET) With Fluorine-18 Fluorodeoxyglucose ([18F]FDG) After First-Line Chemotherapy in Non-Hodgkin's Lymphoma: Is [18F]FDG-PET a Valid Alternative to Conventional Diagnostic Methods?
- Current role of positron emission tomography in thoracic oncology
- Detection of Lymphoma in Bone Marrow by Whole-Body Positron Emission Tomography